Results 151 to 160 of about 38,997 (290)

Haemoglobin A1c Time‐In‐Range and Mortality in Adults With Diabetes

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Reduced A1c time in range and particularly greater time below range are associated with increased mortality in adults with diabetes. A1c stability within person‐specific ranges may be a risk predictor for major outcomes in adults with diabetes. ABSTRACT Introduction Glycemic variability over time is a risk factor for diabetes complications.
Paul R. Conlin   +8 more
wiley   +1 more source

The Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Diabetes remission is possible through weight loss. Behavioural lifestyle program is effective to achieve diabetes remission. ABSTRACT Aims We conducted the diet and diabetes remission (DIREM) study to assess whether an integrated lifestyle intervention would lead to achieving remission in type 2 diabetes.
Negin Badrooj   +9 more
wiley   +1 more source

Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]

open access: yesBMJ Open Diabetes Res Care
Sklepinski S   +15 more
europepmc   +1 more source

A Multicentre, Prospective, Non‐Interventional Single‐Arm Study Investigating the Impact of Once‐Daily Oral Semaglutide in a Real‐World Adult Population With Type 2 Diabetes in Mexico

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Initiation of oral semaglutide in patients with T2D in routine clinical practice in Mexico significantly reduces HbA1c and weight and improves satisfaction with treatment. ABSTRACT Background To investigate the oral semaglutide use among Mexican adults with type 2 diabetes.
Guillermo González‐Gálvez   +7 more
wiley   +1 more source

Depression following the initiation of glucagon‐like‐peptide‐1 receptor agonist therapy: A multinational self‐controlled case series study

open access: yes
Journal of Internal Medicine, Volume 299, Issue 6, Page 776-780, June 2026.
Vincent Ka Chun Yan   +6 more
wiley   +1 more source

Hypolipidemic and Hypoglycemic Activity of Goat Milk–Derived Peptides

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
Goat milk–derived bioactive peptides IASAEPTVH, LSTSEENSKK, and TEDELQDK exerted favorable hypolipidemic and hypoglycemic properties. ABSTRACT The prevalence of diabetes and hyperlipidemia worldwide has increased in recent decades. This study aimed to investigate the potential hypoglycemic and hypolipidemic effects of bioactive peptides derived from ...
Rui Wang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy